Teresa M White, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 |
Kayla Nicole Espolt, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 |
Daniel Cade Montague, OT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 Fax: 601-607-1415 |
Danlee Quinlivan, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 |
Jonathan Moran, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 |
Christy Mchenry, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 711 Avignon Dr, Ridgeland, MS 39157 Phone: 601-605-6777 |
News Archive
Older people who are physically active may be protecting themselves from the effects of small areas of brain damage that can affect their movement abilities, according to a new study published in the March 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
In a new retrospective study, researchers found that the use of immunosuppressive therapy does not increase the occurrence or recurrence of vulvar or vaginal cancer in women with inflammatory bowel disease (IBD).
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.
A working group of virologists headed by Professor Hans-Georg Kräusslich at Heidelberg University Hospitals, jointly with Professor Hanswalter Zentgraf, Division of Applied Tumor Virology of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), have been the first to label Human Immunodeficiency Viruses (HIV) for visual investigations without inhibiting the functional characteristics of the virus.
› Verified 7 days ago